Showing results (961-970 of 5,692) with videos related to

Sort By:
Pageof 570
The Oncologist|January 20, 2021
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal CancerJohn H Strickler, Christel N Rushing, Hope E Uronis, et al.
The Oncologist|October 2, 2019
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric CancerRyan H Moy, Gustavo Dos Santos Fernandes, Philip Jonsson, et al.
The Oncologist|February 4, 2021
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 PandemicGianpiero Fasola, Giacomo Pelizzari, Diego Zara, et al.
The Oncologist|February 8, 2021
Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing DataMatti Aapro, Florian Scotté, Yolanda Escobar, et al.
The Oncologist|February 8, 2021
Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-AnalysisLucas Gonzalez, Ariel Bardach, Alfredo Palacios, et al.
The Oncologist|January 24, 2021
EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic LeukemiaJulio Delgado, Filip Josephson, Jorge Camarero, et al.
The Oncologist|February 21, 2021
Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II TrialJie Xu, Lu Xie, Xin Sun, et al.
The Oncologist|January 26, 2021
Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine TumorsAlex J Liu, Benjamin E Ueberroth, Patrick W McGarrah, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
The Oncologist|October 30, 2016
Chemotherapy Near the End of Life for Chinese Patients with Solid MalignanciesJin Sheng, Ya-Xiong Zhang, Xiao-Bo He, et al.
Pageof 570